Global Good and Motic Introduce Breakthrough
AI-Powered Microscope to Fight Drug-Resistant Malaria
The future of automated quality diagnosis begins now
Global Good and Motic Introduce Breakthrough
AI-Powered Microscope to Fight Drug-Resistant Malaria
The future of automated quality diagnosis begins now.
About Malaria
Every year, malaria kills almost half a million people, and researchers estimate nearly half the world’s population is at risk of contracting it.
The rapid spread of a multidrug-resistant strain in parts of Southeast Asia is a particularly alarming development detailed by researchers in a letter published recently in The Lancet.
“Malaria is one of the hardest diseases to identify on a microscope slide,” said David Bell, Director of Global Health Technologies supporting Global Good. “By putting machine learning-enabled microscopes in the hands of laboratory technicians, we can overcome two major barriers to combating the mutating parasite—improving diagnosis in case management and standardizing detection across geographies and time.”
“This collaboration, combining Global Good’s impact invention focus with Motic’s engineering, manufacturing and distribution capabilities, represents the type of innovative healthcare solution that is needed to improve health in emerging and low-income markets,” said Maurizio Vecchione, Intellectual Ventures’ Executive Vice President of Global Good and Research. “By distributing and commercializing an intelligent microscope, Global Good and Motic are creating a future where quality diagnosis of multiple diseases is within reach for everyone everywhere.”
“Our goal in integrating Global Good’s advanced software into Motic’s high-quality, affordable digital slide scanner is to simplify and standardize malaria detection,” said Richard Yeung, Vice President of Motic China. “Success with the most difficult-to-identify disease paves the way for the EasyScan product line to excel at almost any microscopy task and to detect other major diseases that affect developed and emerging markets alike.”
Motic
Motic is a groundbreaking company specialized in manufacturing conventional compound microscopes. Thanks to our optical expertise, thorough and heartfelt customer service, and aim to enhance the microscopy experience, we have grown into a global brand within everyone’s reach. We are committed to standing by our young scientists from their early steps, improving healthcare, and supporting the progress of scientific research by adapting to the market trends, and by focusing on advanced digital solutions aimed at fulfilling the needs of today and exceeding the expectations of tomorrow.
Intellectual Ventures’ Global Good Fund
Global Good is dedicated to inventing technology for humanitarian impact. Millions of people suffer and die each year in poor countries from causes that humanity has the scientific and technical ability to solve. Funded by Bill Gates and focused on a shared vision with Nathan Myhrvold, Global Good invents technology to solve some of humanity’s most daunting problems. Global Good does this by collaborating with leading humanitarian organizations, forward-looking governments, research institutions, and corporate and private sector partners that bring our inventions
to market.
Accurate detection of severe and drug-resistant cases requires analysis of a blood smear by a
WHO-certified expert microscopist, which takes roughly 20 minutes per slide. Automating the process with an intelligent microscope can alleviate the shortfall of trained personnel in under-resourced countries.
*Motic EasyScan is a product line of Motic Group, all rights reserved.